info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

US Proteomics Market Research Report Information By Equipment (Chromatography, Mass Spectroscopy, and Protein Microarray), By Services (Laboratory Services, Data Analysis & Services, and Others), By Application (Drug Discovery and Clinical Diagnosis), And By Region (North America, Europe, Asia-Pacific, And the Rest Of The World) – Market Forecast Till 2032


ID: MRFR/LS/11828-CR | 100 Pages | Author: Garvit Vyas| December 2023

In 2019, the Americas emerged as the frontrunner in the global microarray market, claiming the largest market share at 40.98%. This dominance is projected to persist throughout the forecast period, mainly attributed to the region's increasing adoption of new technologies and the strong presence of major players. The Americas can be further divided into North America and Latin America. Within North America, comprising the United States and Canada, the growth of the microarray analysis market is bolstered by several key factors. The prevalence of cancer is on the rise in this region, prompting increased funding for research and development, particularly in the field of microarray analysis. Notably, in 2019, the National Institute of Cancer secured funding amounting to approximately USD 42.1 million for cancer research initiatives. Microarrays play a pivotal role in identifying cancer cells and deciphering the genetic structure of these cells. Additionally, the surge in demand for new drugs has led to augmented funding for proteomics and genomics, contributing significantly to the overall market growth. Government backing for research and development has witnessed a notable increase in recent years, translating into elevated funds for cancer research. An illustrative example is the announcement made in February 2019 by the Minister of Science and Sports in Canada, revealing funding of USD 22.7 million. In conjunction with provincial governments contributing USD 33.4 million, this financial support is allocated to bolster 36 research projects under the Genome in Canada initiative. These projects span diverse sectors, including health, agriculture, natural resources, and the environment. Furthermore, collaborations between the Department of Energy and the US National Institutes of Health have resulted in a proliferation of research projects in genomics. Such robust funding for human genome projects is anticipated to drive an increased demand for microarrays. The prevailing trends in North America underscore a strategic alignment between heightened disease research, especially in the cancer domain, and robust financial support from both government and private sectors. This symbiotic relationship is propelling advancements in microarray technology, with a particular focus on cancer detection and genetic analysis. As the region continues to lead in technological adoption and innovation, the microarray market in the Americas remains a dynamic and influential force in the global landscape.

Report Attribute/Metric Details
  Market Size   USD 4649.01 Million
  CAGR   6.90%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Types, Application, Product Type, End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Affymetrix, Inc., Agilent Technologies, Inc., Sequenom, Inc., Roche NimbleGen, Illumnia, Inc., and Applied Microarrays. Other companies operating in the global microarrays market are biomerieux SA, Discerna, Gyros AB, Luminex Corporation, NextGen Sciences, PLC, Thermo Fisher Scientific, and ProteoGenix.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • The Rising Focus on drug discovery, personalized medicines, and targeted therapy are driving the growth of the market.
  • the Rising Prevalence of cancer and increasing investments for cancer research can drive the market growth.


  • Leading companies partner with us for data-driven Insights
    client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
    Kindly complete the form below to receive a free sample of this Report
    Please fill in Business Email for Quick Response

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Purchase Option
    Single User $ 4,950
    Multiuser License $ 5,950
    Enterprise User $ 7,250
    Compare Licenses
    Tailored for You
    • Dedicated Research on any specifics segment or region.
    • Focused Research on specific players in the market.
    • Custom Report based only on your requirements.
    • Flexibility to add or subtract any chapter in the study.
    • Historic data from 2014 and forecasts outlook till 2040.
    • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
    • Provide cross segmentation in applicable scenario/markets.
      Related Reports
    report-img
    US Proteomics